Kurome Therapeutics, a preclinical stage company based in Cincinnati, OH, announced the closing of a $15 million Series A financing. The round was co-led by…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.